If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@ucdenver.edu for more information.
|COMIRB #||Title (Please click on the title to see approved advertisement)||Principal Investigator||Eligibility and Information||Advertisement|
|16-2179||Determining the Optimal Treatment Strategy for Patients who have Chronic Migraine with Medication Overuse||Marius Birlea, MD||Clinical Trials||See Advertisement|
|17-2165||American Registry for Migraine Research||Marius Birlea, MD||Clinical Trials||See Advertisement|
|19-1505||A Parallel Group, Double-Blind, Ranxomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Subjects Experiencing an Acute Attack of Migraine||Marius Birlea, MD||Clinical Trials||N/A|